Rare diseases policy awaits comprehensive implementation 
Business

Rare diseases policy awaits comprehensive implementation 

The National Policy for Rare Diseases (NPRD) 2021 provides a comprehensive framework for the diagnosis and treatment of rare diseases. NPRD classifies rare diseases into

Jes Staley awaits judgment in courtroom battle over ‘Uncle Jeffrey’ Epstein
Finances

Jes Staley awaits judgment in courtroom battle over ‘Uncle Jeffrey’ Epstein

At the end of four days of cross examination, Jes Staley stepped down from the witness stand and hugged his legal team. It had been

Trump tariffs: Indian auto components subject to 25% import tariff in US, sector awaits detailed list
Business

Trump tariffs: Indian auto components subject to 25% import tariff in US, sector awaits detailed list

The Automotive Component Manufacturers Association of India (ACMA) on Thursday said it is waiting for the detailed list of auto components that will be subject

An anxious America awaits Donald Trump’s ‘reciprocal tariffs’
Finances

An anxious America awaits Donald Trump’s ‘reciprocal tariffs’

This is an on-site version of the White House Watch newsletter. You can read the previous edition here. Sign up for free here to get it on

Crude oil futures drop as market awaits outcome of US-Russia talks
Business

Crude oil futures drop as market awaits outcome of US-Russia talks

Crude oil futures traded lower on Monday morning as the US and Russian delegations are set to meet on Monday to discuss a ceasefire plan

UK comic book makers join forces as AI copycat battle awaits
Finances

UK comic book makers join forces as AI copycat battle awaits

Stay informed with free updates Simply sign up to the Media myFT Digest — delivered directly to your inbox. The makers of comic book heroes

Cellogen Therapeutics awaits CDSCO nod for human trial on its ‘bi-specific 3rd generation’ CAR-T therapy
Business

Cellogen Therapeutics awaits CDSCO nod for human trial on its ‘bi-specific 3rd generation’ CAR-T therapy

Biotech start-up Cellogen Therapeutics is awaiting a nod from the Central Drugs Standard Control Organisation (CDSCO) to start its first-in-human (Phase I) trials on its

Nasdaqpicks